Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00334633 · ClinicalTrials.gov registry record · Phase 4
Treatment of Bacterial Vaginosis (BV) With Tinidazole
A Phase 4 study of Bacterial Vaginosis, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 593
- Enrollment target
- 1
- Study location
NCT00334633: Completed Phase 4 study of Bacterial Vaginosis, sponsored by University of Alabama at Birmingham.
NCT00334633 is a Phase 4 study of Bacterial Vaginosis that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 593 participants, above the 299-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (98% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00334633, a Phase 4 study of Bacterial Vaginosis, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 593 participants
- Enrollment target
- 1
- Study location
Study Summary
We are trying to determine if treatment of bacterial vaginosis with tinidazole is better than treatment with metronidazole
Primary Outcome
resolution of Amsel criteria for bacterial vaginosis
Conditions Studied
Interventions
- DRUG tinidazole, metronidazole
Study Locations (1)
Alabama
- Jefferson County Department of Health STD Clinic - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 593 participants |
| Start Date | 2004-11 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
What the finished NCT00334633 record still lists
NCT00334633 is an interventional study that assigns participants to a tested intervention. The registered 593 participants enrollment target is mid-sized for trials with a published cap, above the 299-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (98% higher).
The record links to 1 condition, with Bacterial Vaginosis appearing as the primary indexed condition, and to 1 intervention - of which tinidazole, metronidazole is the first listed.
NCT00334633 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT00334633 about?
NCT00334633 is a clinical study titled "Treatment of Bacterial Vaginosis (BV) With Tinidazole". We are trying to determine if treatment of bacterial vaginosis with tinidazole is better than treatment with metronidazole
What is the current status of trial NCT00334633?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 593 participants. The study started on 2004-11. Estimated completion is 2009-12.
What conditions does trial NCT00334633 study?
This clinical trial studies the following conditions: Bacterial Vaginosis.
What interventions are being tested in trial NCT00334633?
The interventions under investigation include: tinidazole, metronidazole (DRUG).
Who is sponsoring clinical trial NCT00334633?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00334633 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Vaginosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00334633's enrollment target sits among peer trials
593 4th of 15 higher than 12 of 15 other Bacterial Vaginosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bacterial Vaginosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study
COMPLETED · Phase 4
-
Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity
COMPLETED · Phase 4
-
Clinical Protocol CERN Feasibility Study
RECRUITING · NA
-
Prospective Data Bank Creation to Study Vaginal Conditions
RECRUITING
-
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
RECRUITING · Early Phase 1
-
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04701684 · 594 participants · NA
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
- NCT05491213 · 594 participants · NA
TELESCOPE- TELEhealth Shared Decision-making COaching
- NCT05867420 · 594 participants · Phase 1
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
- NCT06890884 · 594 participants · Phase 2
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia